Doseology Sciences Inc. (MOOD.CN)
CAD 0.15
(0.0%)
CAD 0.15
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -319.47 Thousand CAD | 54.43% |
| 2022 | -1.77 Million CAD | 58.03% |
| 2021 | -1.72 Million CAD | -13.51% |
| 2020 | -1.46 Million CAD | -240.9% |
| 2019 | -431.63 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -138.07 Thousand CAD | -129.71% |
| 2023 Q3 | -46.93 Thousand CAD | 66.01% |
| 2023 Q1 | -60.1 Thousand CAD | 47.55% |
| 2023 Q4 | -108.78 Thousand CAD | -131.8% |
| 2022 FY | - CAD | 58.03% |
| 2022 Q1 | -288.6 Thousand CAD | 35.88% |
| 2022 Q4 | -114.6 Thousand CAD | -93.99% |
| 2022 Q3 | -59.07 Thousand CAD | 75.26% |
| 2022 Q2 | -238.75 Thousand CAD | 17.27% |
| 2021 Q1 | -262.77 Thousand CAD | 54.68% |
| 2021 FY | - CAD | -13.51% |
| 2021 Q2 | -469.29 Thousand CAD | -78.59% |
| 2021 Q4 | -450.1 Thousand CAD | 7.3% |
| 2021 Q3 | -485.56 Thousand CAD | -3.47% |
| 2020 Q4 | -579.82 Thousand CAD | -57.92% |
| 2020 Q3 | -367.15 Thousand CAD | 5.06% |
| 2020 FY | - CAD | 0.0% |
| 2020 Q2 | -386.72 Thousand CAD | -180.78% |
| 2020 Q1 | -137.72 Thousand CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -4.98 Million CAD | 93.587% |
| Asep Medical Holdings Inc | -8.13 Million CAD | 96.073% |
| BetterLife Pharma Inc. | -3.19 Million CAD | 89.99% |
| BioVaxys Technology Corp. | -7.68 Million CAD | 95.844% |
| ChitogenX Inc. | -2.69 Million CAD | 88.141% |
| Rapid Dose Therapeutics Corp. | -3.02 Million CAD | 89.438% |
| Defence Therapeutics Inc. | -12.67 Million CAD | 97.48% |
| Entheon Biomedical Corp. | 13.99 Thousand CAD | 2383.127% |
| Gemina Laboratories Ltd. | -5.17 Million CAD | 93.827% |
| Glow Lifetech Corp. | -1.26 Million CAD | 74.706% |
| Lexston Life Sciences Corp. | -648.32 Thousand CAD | 50.722% |
| Pharmala Biotech Holdings Inc. | -710.18 Thousand CAD | 55.015% |
| MYND Life Sciences Inc. | -1.82 Million CAD | 82.496% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | 73.428% |
| PharmaTher Holdings Ltd. | -3.04 Million CAD | 89.502% |
| PreveCeutical Medical Inc. | -955.08 Thousand CAD | 66.55% |
| Telescope Innovations Corp. | -5.49 Million CAD | 94.181% |